Kurve Technology Invited to Speak at SRI's Drug Delivery Technologies and Deal Making Summit
Posted on: Wednesday, 31 August 2005, 09:00 CDT
BOTHELL, Wash., Aug. 31 /PRNewswire/ -- Kurve Technology, Inc. will speak and participate in a panel session on September 28, 2005 at the 10th Annual Drug Delivery Technologies and Deal Making Summit at the Hyatt Regency in New Brunswick, NJ. The conference is sponsored by Strategic Research Institute (SRI).
Kurve's Founder and CEO Marc Giroux will discuss Kurve's ground-breaking Controlled Particle Dispersion (CPD)(TM) technology platform that enables patients to quickly and painlessly administer medications via the nose. The focus of the presentation will be CPD's advantages as a flexible technology platform and how CPD can significantly improve patient compliance. Giroux will demonstrate ViaNase(TM), an advanced nasal drug delivery device that incorporates CPD technology.
Using the principal of vortical flow, CPD effectively disrupts inherent nasal cavity airflows to deliver compounds to the entire nasal cavity. CPD optimizes droplet size and trajectory to saturate the nasal cavity, lengthen compound residence time, and minimize deposition to the lungs. Early indications from clinical investigation show that the average area of intranasal deposition was as much as 300 percent greater for ViaNase compared to nasal spray bottles.
Information on the SRI Conference can be found online at http://www.srinstitute.com/.
About Kurve Technology, Inc.
Kurve Technology, Inc. offers pharmaceutical companies versatile nasal delivery systems for local and systemic medical therapies. Kurve's Controlled Particle Dispersion (CPD)(TM) technology intranasally delivers compounds with far greater efficacy and efficiency than traditional methods. ViaNase(TM) -- an electronic atomizer that incorporates CPD -- can deliver a wide range of compounds, aiding the more than 200 million patients who suffer from such medical conditions as allergic rhinitis, chronic rhinosinusitis, sexual dysfunction, migraine headache, obesity, and CNS disease. Kurve Technology is headquartered in Bothell, Washington with an office in Research Triangle Park, North Carolina. http://www.kurvetech.com/
Contact for Kurve Technology: Christine Slocumb Kurve Technology, Inc. 425-640-9249 cslocumb@kurvetech.com
Kurve Technology, Inc.
CONTACT: Christine Slocumb of Kurve Technology, Inc., +1-425-640-9249,or cslocumb@kurvetech.com
Web site: http://www.kurvetech.com/
Source: PRNewswire
Related Articles
- Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook
- DelSite Presents Nasal Powder and Synthetic Typhoid Vaccine Technologies at the 2nd Vaccines Asia Conference
- Investing in Drug Delivery Technologies: Fighting Patent Expiries
- DelSite Biotechnologies Nasal Powder Vaccine Platform Highlighted At Cambridge Healthtech Institute
- PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
- Kurve Technology Signs Agreement With Schering-Plough Corporation
- Kurve Technology Moves to New Corporate Headquarters
- Experimental Cavity Fighting Complex Significantly More Effective Than Fluoride
- Kurve Technology Invited to Speak at Nasal Drug Delivery Conference
 |
 |
User Comments (0)
RSS Feeds